Literature DB >> 26582828

Development of an Enzyme-Linked Immunosorbent Assay Based on Fusion VP2332-452 Antigen for Detecting Antibodies against Aleutian Mink Disease Virus.

Xiaowei Chen1, Cailing Song1, Yun Liu1, Liandong Qu1, Dafei Liu1, Yun Zhang2, Ming Liu2.   

Abstract

For detection of Aleutian mink disease virus (AMDV) antibodies, an enzyme-linked immunosorbent assay (ELISA) was developed using the recombinant VP2332-452 protein as an antigen. Counterimmunoelectrophoresis (CIEP) was used as a reference test to compare the results of the ELISA and Western blotting (WB); the specificity and sensitivity of the VP2332-452 ELISA were 97.9% and 97.3%, respectively, which were higher than those of WB. Therefore, this VP2332-452 ELISA may be a preferable method for detecting antibodies against AMDV.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26582828      PMCID： PMC4733201          DOI： 10.1128/JCM.02625-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  DNA vaccination with the Aleutian mink disease virus NS1 gene confers partial protection against disease.

Authors:  Yurdana Castelruiz; Merete Blixenkrone-Møller; Bent Aasted
Journal:  Vaccine       Date:  2005-01-26       Impact factor: 3.641

2.  Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay.

Authors:  Yongjun Jiao; Xiaoyan Zeng; Xiling Guo; Xian Qi; Xiao Zhang; Zhiyang Shi; Minghao Zhou; Changjun Bao; Wenshuai Zhang; Yan Xu; Hua Wang
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

3.  Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.

Authors:  M E Bloom; D A Martin; K L Oie; M E Huhtanen; F Costello; J B Wolfinbarger; S F Hayes; M Agbandje-McKenna
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Identification and expression of Babesia ovis secreted antigen 1 and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.

Authors:  Ferda Sevinc; Shinuo Cao; Xuenan Xuan; Mutlu Sevinc; Onur Ceylan
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

5.  Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.

Authors:  M E Bloom; S M Best; S F Hayes; R D Wells; J B Wolfinbarger; R McKenna; M Agbandje-McKenna
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Expression of infectious laryngotracheitis virus glycoproteins in Escherichia coli and their application in enzyme-linked immunosorbent assay.

Authors:  Poa-Chun Chang; Kwan-Ting Chen; Jui-Hung Shien; Happy K Shieh
Journal:  Avian Dis       Date:  2002 Jul-Sep       Impact factor: 1.577

7.  Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture.

Authors:  M E Bloom; B D Berry; W Wei; S Perryman; J B Wolfinbarger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease.

Authors:  B Aasted; S Alexandersen; J Christensen
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

9.  Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid.

Authors:  M L Strassheim; A Gruenberg; P Veijalainen; J Y Sgro; C R Parrish
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

10.  Development and evaluation of an enzyme-linked immunosorbent assay based on recombinant VP2 capsids for the detection of antibodies to Aleutian mink disease virus.

Authors:  Anna Knuuttila; Pirjo Aronen; Auli Saarinen; Olli Vapalahti
Journal:  Clin Vaccine Immunol       Date:  2009-07-29
View more
  3 in total

1.  Development of an antigen-capture enzyme-linked immunosorbent assay for diagnosis of Aleutian mink disease virus.

Authors:  Taofeng Lu; Yuanzhi Wang; Yanjun Wu; Lili Zhao; Shuguang Wu; Hongyan Chen
Journal:  Arch Virol       Date:  2020-10-17       Impact factor: 2.574

2.  Development of a Peptide ELISA for the Diagnosis of Aleutian Mink Disease.

Authors:  Fanshu Ma; Lei Zhang; Yang Wang; Rongguang Lu; Bo Hu; Shuang Lv; Xianghong Xue; Xintong Li; Mingyu Ling; Sining Fan; Hailing Zhang; Xijun Yan
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

Review 3.  AMDV Vaccine: Challenges and Perspectives.

Authors:  Nathan M Markarian; Levon Abrahamyan
Journal:  Viruses       Date:  2021-09-14       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.